Diffusion Pharmaceuticals Stock Price

-0.09 (-7.96%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Diffusion Pharmaceuticals Inc DFFN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.09 -7.96% 1.04 07:38:19
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
1.05 1.06 0.01 - -
Trades Volume Avg Volume 52 Week Range
65 30,654 2,503,616 0.241 - 1.89
Last Trade Time Type Quantity Stock Price Currency
07:34:27 formt 151 $ 1.04 USD

Diffusion Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 66.58M 64.02M 63.94M $ - $ - -1.79 113.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Diffusion Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DFFN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.291.451.051.154,418,312-0.25-19.38%
1 Month0.681.450.6761.103,162,8470.3652.94%
3 Months0.831.450.61290.94992561,800,7970.2125.3%
6 Months1.271.700.61291.031,708,579-0.23-18.11%
1 Year0.511.890.2410.83865183,433,5030.53103.92%
3 Years10.81511.250.2111.301,712,701-9.78-90.38%
5 Years15.75232.500.2114.071,152,282-14.71-93.4%

Diffusion Pharmaceuticals Description

Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM); Phase II pancreatic cancer; and metastatic brain cancer.

Your Recent History
Diffusion ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.